| # | Drug | Count |
|---|---|---|
| 0 | VENETOCLAX | 445 |
| 1 | LENALIDOMIDE | 333 |
| 2 | ADALIMUMAB | 313 |
| 3 | RANITIDINE | 302 |
| 4 | RUXOLITINIB | 266 |
| 5 | METHOTREXATE SODIUM | 254 |
| 6 | PREDNISONE | 253 |
| 7 | IMATINIB MESYLATE | 226 |
| 8 | METHOTREXATE | 219 |
| 9 | ETANERCEPT | 216 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIFLUOPERAZINE HYDROCHLORIDE | 19 | 0.1508 |
| 1 | PERPHENAZINE | 83 | 0.0398 |
| 2 | ZIPRASIDONE HCL | 76 | 0.0286 |
| 3 | LOXAPINE | 74 | 0.0185 |
| 4 | HALOPERIDOL DECANOATE | 31 | 0.0178 |
| 5 | AMISULPRIDE | 87 | 0.0142 |
| 6 | RYDAPT | 27 | 0.0138 |
| 7 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE | 2 | 0.0129 |
| 8 | MOMELOTINIB | 17 | 0.0115 |
| 9 | ZIPRASIDONE | 38 | 0.0105 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 594 |
| 1 | Kinase Inhibitor [EPC] | 501 |
| 2 | BCL-2 Inhibitor [EPC] | 445 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 409 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 372 |
| 5 | Thalidomide Analog [EPC] | 353 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 341 |
| 7 | Janus Kinase Inhibitor [EPC] | 324 |
| 8 | Azole Antifungal [EPC] | 281 |
| 9 | Alkylating Drug [EPC] | 258 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Catecholamine Synthesis Inhibitor [EPC] | 1 | 0.0123 |
| 1 | Dopamine-2 Receptor Antagonist [EPC] | 87 | 0.0112 |
| 2 | BCL-2 Inhibitor [EPC] | 445 | 0.0071 |
| 3 | Iron Chelator [EPC] | 189 | 0.0065 |
| 4 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 85 | 0.0040 |
| 5 | CD33-directed Immunoconjugate [EPC] | 14 | 0.0038 |
| 6 | Phenothiazine [EPC] | 105 | 0.0035 |
| 7 | Typical Antipsychotic [EPC] | 82 | 0.0033 |
| 8 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 8 | 0.0032 |
| 9 | Human Immunoglobulin G [EPC] | 65 | 0.0031 |